The cost-effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan.

Both maternal and universal newborn screening strategies may be cost-effective than a targeted newborn screening program. The potential utility of the maternal screening with valacyclovir treatment strategy, while potentially cost effective in regions with lower baseline seroprevalence rates, requires further study as the modeling was based on limited evidence. This article is protected by copyright. All rights reserved.